Dow Chemical Co (DOW)

DOW (:Chemicals) EQUITY
$52.61
pos +0.00
+0.00%
Today's Range: 52.28 - 53.69 | DOW Avg Daily Volume: 7,099,600
Last Update: 04/29/16 - 4:01 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $53.42
52 Week Range: $35.11 - $57.10
Oustanding Shares: 1,117,112,448
Market Cap: 59,676,146,972
6-Month Chart
TheStreet Ratings Grade for DOW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 5
Moderate Buy 1 1 1 2
Hold 6 6 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.00 2.07 2.14
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
DOW Sector Avg. S&P 500
0.00 9.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue -16.10 -0.10 -0.05
Net Income 102.70 6.10 0.91
EPS 104.60 8.10 1.07
Earnings for DOW:
EBITDA 8.48B
Revenue 48.78B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.89 $0.84 $3.45 $4.01
Number of Analysts 8 7 9 8
High Estimate $0.94 $0.95 $3.60 $4.15
Low Estimate $0.82 $0.75 $3.25 $3.80
Prior Year $0.91 $0.82 $3.47 $3.45
Growth Rate (Year over Year) -2.61% 2.61% -0.70% 16.42%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Bullish
Apr 29, 2016 | 7:49 AM EDT
Shares of DOW now seen reaching $57, according to Credit Suisse. Estimates also upped, as the company is realizing higher margins acros...
If Dow's proposed merger with DuPont fails, the company could still benefit from its early investments in ethylene production.
Reduced expectations for future rate hikes are a negative for our financials but good for our higher dividend-paying stocks.
What does Gundlach have to say now that oil and the market are rising?

Looking to Buy More DuPont Real Money Pro($)

I'm a buyer of DuPont (DD) between $60 to $61.

My Takeaways and Observations Real Money Pro($)

The market did its best to wear out the bears. Opening lower, Mr. Market had a rather violent move to the upside (a reversal of about 20 S&P handles). It closed the day back almost where it started. The U.S. dollar was slightly weaker. Bonds flatlined. The 10-year yield rose by two basis points and the long bond was unchanged. Municipals were dead flat and so were closed-end municipal bond funds. The junk bond market was up marginally, but Blackstone/GSO Strategic Credit Fund (BGB) got hit for six cents after a reasonably good run. Crude oil was an upside feature, gaining $1.97 to $37.89 even though some sage advisers said it would never rise above $40 a barrel for years. Nat gas increased by three cents. Gold fell by $2 to $1,268. Agricultural commodities exhibited little movement in price, with soybeans, corn and wheat barely moving. Oats were up 5.25. Lumber was up $7.70. Financials were little changed to down. Banks were a bit lower, as were brokerages. Retail was quite strong. Wal-Mart (WMT), Best Buy (BBY) and Bed, Bath & Beyond (BBBY), which I sold in the a.m., were all up substantially. Biotech was up 2%, led by Valeant Pharmaceuticals (VRX). But Allergan (AGN) was down $2. Old tech was led by IBM (IBM), up $2, but Microsoft (MSFT) was down $1.30 after recent strong gains. Airlines got pressured by crude's price rise. Autos were mixed, with Ford (F) higher and General Motors (GM) lower. I am short both! Consumer staples got hit and are extended. Best Ideas List long Procter & Gamble (PG) was down by 30 cents.  My previously owned Biotech Basket prospered, led by Intrexon (XON), which was featured in a Saturday New York Times article. Nektar Therapeutics (NKTR), Sage Therapeutics (SAGE), Portola Pharmaceuticals (PTLA), Celgene (CELG) and Gilead Sciences (GILD) all were higher. Energy stocks followed the price of crude. Exxon Mobil (XOM) was up $1.75 and Schlumberger (SLB) rose 90 cents. (T)FANGs lost their bite today.  NOSH was broadly lower, with Nike (NKE) and Starbucks (SBUX) leading lower. CRABBY's six components were all down on the day. DuPont (DD), my large-cap stock of the year, was higher but Dow Chemical (DOW) was lower as BASF expressed takeover interest in DD. I will have more on this tomorrow. I am holding to my position. Good stuff on RealMoneyPro today: 1. Gary Morrow on Facebook's breakdown  2.  Jim "El Capitan" Cramer on the commodities market  3.  Mark "Nashville Cats" Sebastian on spotting a short squeeze  4.  Jeremy LaKosh on the labor market   5.  Tim Melvin on the

Columnist Conversations

Mine and many other reviews of the meeting coming Monday, but the quick highlights to whet your appetite: 1)...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.